reference/20346944

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20346944

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1874-3919
pageRange	104197-
publicationName	Journal of Proteomics
startingPage	104197
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8c731652e0c1f6c196881324ed2185f6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0b022cc297f914202001474893e3718a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3480811aab6aa35b08ca5d191874c22b
bibliographicCitation	Porras-Yakushi TR, Reitsma JM, Sweredoski MJ, Deshaies RJ, Hess S. In-depth proteomic analysis of proteasome inhibitors bortezomib, carfilzomib and MG132 reveals that mortality factor 4-like 1 (MORF4L1) protein ubiquitylation is negatively impacted. J Proteomics. 2021 Jun 15;241():104197. doi: 10.1016/j.jprot.2021.104197. PMID: 33848640.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1112a0d208e6c7d93936435944fd48eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_813c8c062a7b466081681e98840d8c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32a107369d4a5f7039154cab4ce5e4ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e4b73a69bfa41964541b314ac12cb10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a8e937a1a5a371c0e78b9c87535e812
date	2021-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.jprot.2021.104197 https://pubmed.ncbi.nlm.nih.gov/33848640
isPartOf	https://portal.issn.org/resource/ISSN/1874-3919 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34573
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	In-depth proteomic analysis of proteasome inhibitors bortezomib, carfilzomib and MG132 reveals that mortality factor 4-like 1 (MORF4L1) protein ubiquitylation is negatively impacted
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0015279 http://id.nlm.nih.gov/mesh/M0196512 http://id.nlm.nih.gov/mesh/M0560885 http://id.nlm.nih.gov/mesh/M0140424 http://id.nlm.nih.gov/mesh/M0516378 http://id.nlm.nih.gov/mesh/M0350110 http://id.nlm.nih.gov/mesh/M0012428
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D000970Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061988Q000494 http://id.nlm.nih.gov/mesh/D040901 http://id.nlm.nih.gov/mesh/D054875 http://id.nlm.nih.gov/mesh/D000069286Q000627 http://id.nlm.nih.gov/mesh/D000069286Q000494 http://id.nlm.nih.gov/mesh/D007976 http://id.nlm.nih.gov/mesh/D046988Q000378 http://id.nlm.nih.gov/mesh/D009842 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D061988Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8b844ec4b8f2074421b1af2c25f4e4f6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11556711 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID462382 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1

Total number of triples: 53.